Riskpilot← Back to searchSign inGet full accessRehabera AB
ABActiveOrg 5592503386Skeppsbron 46Diagnostic imaging services and medical laboratory activities · NACE 8691Est. 20202 employees
Revenue 2025
SEK 8,8M
+385% vs 2024
EBITDA margin
41.4%
+339% vs 2024
Equity ratio
70.0%
Financial strength
Net profit 2025
SEK 2,9M
+312% vs 2024
| Revenue | SEK 8,8M | +385% |
| EBITDA | SEK 3,6M | +339% |
| Net profit | SEK 2,9M | +312% |
| Total assets | SEK 4,1M | +279% |
| Equity | SEK 2,9M | +299% |
| Employees | 2 | — |
Legal name
Rehabera AB
Org number
5592503386
Legal form
Aktiebolag
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
30 mars 2020
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Kvalificerade provtagningar avseende alkohol och droger för företag och privatpersoner. Tjänster gällande upprättande av policys, utbildning och föreläsningar om detsamma. Läkartjänster, rehabtjänster och behandling gällande missbruk och beroende.
Address
Skeppsbron 46
Email
johannes@kriisa.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 100 | 264 | 430 | 1 807 | 8 754 |
| Staff expenses | — | — | −596 | −70 | −1 366 |
| EBITDA | 88 | 157 | −214 | 827 | 3 628 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 88 | 157 | −214 | 827 | 3 628 |
| Net financials | — | −0 | −0 | −0 | 3 |
| Profit before tax | 88 | 157 | −214 | 827 | 3 631 |
| Tax | −18 | −32 | — | −127 | −752 |
| Net profit | 70 | 125 | −214 | 699 | 2 879 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 150 | 407 | 132 | 1 095 | 4 149 |
| Equity | 94 | 219 | −26 | 728 | 2 904 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 56 | 188 | 158 | 367 | 1 245 |
| Total debt | 56 | 188 | 158 | 367 | 1 245 |
EBITDA margin
41.4%
This company
15.8%
Market median
+162% vs market
20212025
Equity ratio
70.0%
This company
38.2%
Market median
+83% vs market
20212025
Return on equity
99.1%
This company
18.4%
Market median
+439% vs market
20212025
Net profit margin
32.9%
This company
8.1%
Market median
+306% vs market
20212025
Asset turnover
2.11×
This company
1.12×
Market median
+88% vs market
20212025
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2026 | |
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Skeppsbron Brygg & Bygg Aktiebolag
Rehabera AB Board members of Rehabera AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Conny Christian Högstedt | Deputy Board Member | 0 companies |
| Jan Gabriel Erik Julian Jansson | Chairman | 0 companies |
| Johannes Kriisa | Board of Directors | 0 companies |